GDF2 variant enrichment was recently reported in three large PAH cohorts, strongly implicating the BMP9/BMP10/ALK1/BMPR2 signalling pathway in PAH pathobiology [10,12,20]. This evidence concerns the gene GDF2 and pulmonary arterial hypertension.